Welcome to Medications.com
Youre adding a drug to your cabinet. Login or Signup to complete this action, or Cancel.

Schering-Plough posts $3.4B loss in 4Q on charges related to ... - PR-Inside.com (Pressemitteilung)

Key profit drivers for Schering-Plough include the arthritis treatment Remicade and the allergy treatment Nasonex. Quarterly Remicade sales rose 35 percent ...

http://www.pr-inside.com/schering... | Posted: Wed Feb 13 13:33:33 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea